COMPANIES COVERED
BayerDownload FREE Report Sample
Download Free sampleRetinal drugs are the medications that are used for the treatment of retinal diseases
Retinal Drugs Market contains market size and forecasts of Retinal Drugs in global, including the following market information:
Global Retinal Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Retinal Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Retinal Drugs companies in 2021 (%)
The global Retinal Drugs market was valued at 24780 million in 2021 and is projected to reach US$ 34920 million by 2028, at a CAGR of 5.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Wet AMD Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Retinal Drugs include Bayer, F. Hoffmann-La Roche, Novartis, Regeneron, Merck, Takeda, Teva Pharmaceutical and ThromboGenics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Wesurveyed the Retinal Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Retinal Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Retinal Drugs Market Segment Percentages, by Type, 2021 (%)
Wet AMD
Diabetic Retinopathy
DME
RVO
Mcnv
Global Retinal Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Retinal Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitial
Clinicl
Others
Global Retinal Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Retinal Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Retinal Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Retinal Drugs revenues share in global market, 2021 (%)
Key companies Retinal Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Retinal Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
F. Hoffmann-La Roche
Novartis
Regeneron
Merck
Takeda
Teva Pharmaceutical
ThromboGenics
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
